Analysis of genetic polymorphisms for predicting response to treatment and progression of prostate tumor

Analysis of genetic polymorphisms for predicting response to treatment and progression of prostate tumor - Polymorphisms for Predicting Progression of Prostate tumor (PoPProP trial)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000009785

Enrollment

200

Registered

2013-02-01

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. Prostate cancer patients 20 years old or older 2. Pathologically diagnosed prostate cancer 3. Clinical stage: TanyNanyM1

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Significant association between SNPs and cancer-specific survival	—

Secondary

Measure	Time frame
Significant association between SNPs and 1. Overall survival 2. Time to castration resistant prostate cancer (CRPC) 3. Time to any death from CRPC 4. Time to cancer death from CRPC	—

Countries

Japan,Asia(except Japan),North America,Europe

Contacts

Public ContactNorihiko Tsuchiya

Yamagata University Faculty of Medicine Department of Urology

ntsuchiya@med.id.yamagata-u.ac.jp023-628-5368

Outcome results